Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice
- Brigitte Dumartin*,
- Mohamed Jaber*,
- Francois Gonon*,
- Marc G. Caron†,
- Bruno Giros‡, and
- Bertrand Bloch*,§
- *Laboratoire d'Histologie-Embryologie, Unite Mixte de Recherche Centre National de la Recherche Scientifique 5541, Interactions Neuronales et Comportements, Université V. Ségalen, 146 Rue Léo-Saignat, 33076 Bordeaux Cedex, France; †Howard Hughes Medical Institute Laboratories, Departments of Cell Biology and Medicine, Duke University Medical Center, Durham, NC 27710; and ‡Unité Institut National de la Sante et de la Recherche Medicale 513, Faculté de Médecine, 8 Avenue du Général Sarrail, 94010 Créteil Cedex, France.
-
Edited by Tomas Hökfelt, Karolinska Institute, Stockholm, Sweden, and approved November 4, 1999 (received for review August 11, 1999)
Abstract
In vivo, G protein-coupled receptors (GPCR) for neurotransmitters undergo complex intracellular trafficking that contribute to regulate their abundance at the cell surface. Here, we report a previously undescribed alteration in the subcellular localization of D1 dopamine receptor (D1R) that occurs in vivo in striatal dopaminoceptive neurons in response to chronic and constitutive hyperdopaminergia. Indeed, in mice lacking the dopamine transporter, D1R is in abnormally low abundance at the plasma membrane of cell bodies and dendrites and is largely accumulated in rough endoplasmic reticulum and Golgi apparatus. Decrease of striatal extracellular dopamine concentration with 6-hydroxydopamine (6- OHDA) in heterozygous mice restores delivery of the receptor from the cytoplasm to the plasma membrane in cell bodies. These results demonstrate that, in vivo, in the central nervous system, the storage in cytoplasmic compartments involved in synthesis and the membrane delivery contribute to regulate GPCR availability and abundance at the surface of the neurons under control of the neurotransmitter tone. Such regulation may contribute to modulate receptivity of neurons to their endogenous ligands and related exogenous drugs.
Footnotes
-
↵ § To whom reprint requests should be addressed. E-mail: bertrand.bloch{at}u-bordeaux2.fr.
-
This paper was submitted directly (Track II) to the PNAS office.
- Abbreviations:
- GPCR,
- G protein-coupled receptor;
- D1R,
- D1 dopamine receptor;
- DAT,
- dopamine transporter;
- MFB,
- medial forebrain bundle;
- DOPAC,
- 3,4-dihydroxyphenylacetic acid;
- 6-OHDA,
- 6-hydroxydopamine
- Copyright © 2000, The National Academy of Sciences





